KARA BABAIAN to Disease-Free Survival
This is a "connection" page, showing publications KARA BABAIAN has written about Disease-Free Survival.
Connection Strength
0.069
-
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Gu?rin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Gu?rin Treatment. Clin Genitourin Cancer. 2024 Jun; 22(3):102059.
Score: 0.045
-
Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent. Urol Oncol. 2015 Apr; 33(4):166.e21-9.
Score: 0.024